Xinggui 田兴贵 Tian

Dr. Xinggui 田兴贵 Tian

Departments of Orthopedic Surgery, Stanford Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CMChuying Ma
Chuying Ma
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
JKJimin P. Kim
Jimin P. Kim
DXDenghui Xie
Denghui Xie
XAXiang Ao
Xiang Ao
JYJian Yang
Jian Yang
Significance: Differentiation of mesenchymal stem cells (MSCs) to bone-forming cells is central to bone regeneration, the extent of which is largely regulated by microenvironment factors. Here, we find that citrate as a metabolic factor that is abundant in bone can be consumed by MSCs to fuel osteogenesis by regulating metabolic pathways. We explored the mechanism of citrate benefit and designed a biomimetic citrate-based material that could provide a citrate- and phosphoserine-rich environment during degradation based on the previously unexplored concerted action between the two bioactive factors in accelerating bone regeneration. Together, these studies open up avenues for the study of stem cell biology and design of bone biomaterials to treat critically sized defects and bone disorders of metabolic origin.

25 September 2022 in Advanced Materials
Verified
Journal Article
Closed access
QTQinyu Tian
Qinyu Tian
WWWeiwen Wang
Weiwen Wang
LCLijian Cao
Lijian Cao
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
GTGuangzhao Tian
Guangzhao Tian
QGQuanyi Guo
Quanyi Guo

1 September 2018 in Bone
Verified
Journal Article
Closed access
HCHongdong Chen
Hongdong Chen
YWYeyang Wang
Yeyang Wang
HDHuaiqian Dai
Huaiqian Dai
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
ZCZhong-Kai Cui
Zhong-Kai Cui
XBxiaochun Bai
xiaochun Bai

30 April 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
JGJinshan Guo
Jinshan Guo
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
DXDenghui Xie
Denghui Xie
KRKevin Rahn
Kevin Rahn
EGEthan Gerhard
Ethan Gerhard
JYJian Yang
Jian Yang

13 April 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
HJHuaji Jiang
Huaji Jiang
YCYuhui Chen
Yuhui Chen
GCGuorong Chen
Guorong Chen
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
JTJiajun Tang
Jiajun Tang
CXCory J. Xian
Cory J. Xian

1 May 2020 in Medicine
Verified
Journal Article
Open access
FLFei Lei
Fei Lei
ZLZhongyang Li
Zhongyang Li
WHWen He
Wen He
Xinggui 田兴贵 TianXinggui 田兴贵 Tian
Xinggui 田兴贵 Tian
LZLipeng Zheng
Lipeng Zheng
DFDaxiong Feng
Daxiong Feng
Hidden blood loss (HBL) plays an important role in perioperative rehabilitation of patients underwent posterior lumbar fusion surgery. This study was to calculate the volume of HBL and evaluate the risk factors among patients after posterior lumbar fusion surgery. A retrospective analysis was made on the clinical data of 143 patients underwent posterior lumbar fusion surgery from March 2017 to December 2017. Recording preoperative and postoperative hematocrit to calculate HBL according to Gross formula and analyzing its related factors including age, sex, height, weight, body mass index (BMI), surgery levels, surgical time, surgery types, duration of symptoms, disorder type, specific gravity of urine (SGU), plasma albumin (ALB), glomerular filtration rate (GFR), glucose (GLU), drainage volume, hypertension. Risk factors were further analyzed by multivariate linear regression analysis and t test. Eighty-six males and 57 females, mean age 52.7 ± 11.4 years, mean height 162 ± 7.0, mean weight 61.5 ± 9.4, were included in this study. The HBL was 449 ± 191 mL, with a percentage of 44.2% ± 16.6% in the total perioperative blood loss. Multivariate linear regression analysis revealed that patients with higher BMI (P = .026), PLIF procedures (P = .040), and more surgical time (P = .018) had a greater amount of HBL. Whereas age (P = 0.713), sex (P = .276), surgery levels (P = .921), duration of symptoms (P = .801), disorder type (P = .511), SGU (P = .183), ALB (P = .478), GFR (P = .139), GLU (P = .423), hypertension (P = .337) were not statistically significant differences with HBL. HBL is a large proportion of total blood loss in patients after posterior lumbar fusion surgery. BMI >24 kg/m2, PLIF procedures, and more surgical time are risk factors of HBL. Whereas age, sex, surgery levels, duration of symptoms, disorder type, SGU, ALB, GFR, GLU, hypertension were not associated with HBL.